𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Steady-state pharmacokinetics of indobufen enantiomers in patients with obliterative atherosclerosis

✍ Scribed by F.K. Główka; D. Strzelecka; S. Zapalski

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
128 KB
Volume
13
Category
Article
ISSN
0899-0042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

STEADY STATE PHARMACOKINETICS OF CARBAMA
STEADY STATE PHARMACOKINETICS OF CARBAMAZEPINE--PHENOBARBITAL INTERACTION IN PATIENTS WITH EPILEPSY
✍ S. Sennoune; A. Iliadis; J. Bonneton; Y. Barra; P. Genton; E. Mesdjian 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Two carbamazepine (CBZ) tablet formulations (conventional, CBZ-CO, or controlled release, CBZ-CR) are commonly prescribed in monotherapy or in comedication with phenobarbital (PB) in the treatment of epilepsies. This study compares the pharmacokinetics of CBZ-CO against CBZ-CR in patients with epile

Steady-state pharmacokinetics of the ena
Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans
✍ Jagdev Sidhu; Morten Priskorn; Mette Poulsen; Alain Segonzac; Gilles Grollier; F 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

The steady-state pharmacokinetics in serum and urine of the enantiomers of citalopram and its metabolites, demethylcitalopram (DCT) and didemethylcitalopram (DDCT), were investigated after multiple doses of rac-citalopram for 21 consecutive days (40 mg per day) to healthy human subjects who were ext

Enantioselectivity in the steady-state p
Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients
✍ Paula Macedo Cerqueira; Evandro José Cesarino; Fabiano Henrique Mateus; Yussif M 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

In the present study we investigated the enantioselectivity in the pharmacokinetics of metoprolol administered in a multiple-dose regimen as the racemate. The study was conducted on 10 patients of both sexes with mild to severe essential hypertension, aged 28 to 76 years, with normal hepatic and ren

Steady state pharmacokinetics of piroxic
Steady state pharmacokinetics of piroxicam in children with rheumatic diseases
✍ A.-L. Mäkelä; K. T. Olkkola; M. J. Mattila 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 238 KB

Ten children with rheumatoid arthritis, aged 7-16 y and weighing 20-63 kg, were treated with piroxicam mean dose 0.4 mg.kg-1 once daily for 2 weeks. On Day 15, blood was sampled from 2-120 h after the last dose. The Cmax for piroxicam ranged from 3.6 to 9.8 (mean 6.6) mg.l-1 and its half-life by log